A study co-authored by MCB and Chemistry Professors Jamie Cate and Jennifer Doudna found a new method to selectively target disease-bearing proteins without damaging the cells containing them. This technology could lead to an alternative to antibiotic treatments, and could have implications for treating cancer and neurological diseases.
Source: PLOS Biology